Changhua, Taiwan

Kun-Tu Yeh


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: Kun-Tu Yeh: Innovator in Cancer Detection and Treatment

Introduction

Kun-Tu Yeh is a prominent inventor based in Changhua, Taiwan. He has made significant contributions to the field of cancer research, particularly through his innovative work on antibodies. His research focuses on the development of anti-EGF like domain multiple 6 (EGFL6) antibodies, which play a crucial role in cancer detection and treatment.

Latest Patents

Kun-Tu Yeh holds a patent for the invention titled "Anti-EGF like domain multiple 6 (EGFL6) antibodies." This invention relates to the creation of anti-EGFL6 antibodies, specifically single-chain antibody fragments (scFv) and humanized antibodies. These antibodies have demonstrated the ability to bind to EGFL6, inhibiting angiogenesis and cancer cell growth. This groundbreaking work has the potential to enhance cancer diagnosis and therapeutic strategies.

Career Highlights

Throughout his career, Kun-Tu Yeh has been associated with notable institutions such as Taipei Medical University and Changhua Christian Medical Foundation Changhua Christian Hospital. His work in these organizations has allowed him to advance his research and contribute to the medical community.

Collaborations

Kun-Tu Yeh has collaborated with esteemed colleagues, including Yu-Ching Lee and Shiow-Lin Pan. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

Kun-Tu Yeh's innovative work in developing anti-EGFL6 antibodies marks a significant advancement in cancer detection and treatment. His contributions to the field are invaluable and continue to inspire future research in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…